Mirati Therapeutics
Patents, Design & Utilities
Last updated:
List of all Mirati Therapeutics patents 27 in total
| Status | Patent |
|---|---|
Application | Utility: IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: COMBINATION THERAPIES Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: COMBINATION THERAPIES Filling date: 6 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: COMBINATION THERAPIES Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: COMBINATION THERAPIES Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: COMBINATION THERAPIES Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Filling date: 6 Sep 2025 Issue date: 11 Jan 2022 |
Application | Utility: KRAS G12C INHIBITORS Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: KRAS G12C INHIBITORS Filling date: 6 Sep 2025 Issue date: 2 Sep 2021 |
Grant | Utility: Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Filling date: 6 Sep 2025 Issue date: 17 Aug 2021 |
Application | Utility: PRC2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: KRAS G12C INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: SOS1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: PRC2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: COMBINATION THERAPIES Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: MTA-Cooperative PRMT5 Inhibitors Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: MTA-Cooperative PRMT5 Inhibitors Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: PRC2 Inhibitors Filling date: 6 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: KRAS G12C INHIBITORS Filling date: 6 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: KRAS G12C INHIBITORS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: KRAS G12C INHIBITORS Filling date: 6 Sep 2025 Issue date: 20 Aug 2020 |
Grant | Utility: KRas G12C inhibitors Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: KRas G12C inhibitors Filling date: 6 Sep 2025 Issue date: 12 May 2020 |
Grant | Utility: KRas G12C inhibitors Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Application | Utility: KRAS G12C INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Sep 2019 |
Showing 1 to 27 of 27 patents.